
Neopharma Pharmaceutical Plant, Abu Dhabi
Neopharma opened a new pharmaceutical plant in Abu Dhabi, United Arab Emirates, in July 2003.
Metrohm is the global market leader in the fields of titration and voltammetry, and one of the leading innovators in ion chromatography, online analysis and laboratory automation.
Metrohm is the only company providing all relevant ion analysis technologies under one roof: potentiometric and Karl Fischer titration, voltammetry and ion chromatography, as well as pH, ion, conductivity and oxidation stability measurements. Additionally, we offer instrument software, method-specific software packages, and peripheral units, as well as a full range of systems for dosing and liquid handling.
With regard to the quality and safety of drugs, authorities worldwide set high standards for the pharmaceutical industry. These are documented in pharmacopoeias in the form of official collections of recognised pharmaceutical rules. As legal tools of consumer protection, they ensure that drugs are used safely.
To ensure these high quality and safety standards, reliable instruments and methods are needed.
As a leading manufacturer of instruments for titration, ion chromatography and pH measurement, Metrohm is aware of these challenges. For this reason, Metrohm offers you not only the latest instruments, but complete solutions for very specific analytical issues.
Your Metrohm contacts are competent specialists, who will develop customised applications and provide you with professional support in all matters of regulatory compliance.
Discover what solutions Metrohm is able to offer the pharmaceutical sector, and you in particular, to ensure the quality and safety of your products.
Thanks to its modular concept, the Titrando system can easily be adapted to any application. It meets the requirements of FDA regulation 21 CFR Part 11, irrespective of its use as stand-alone titrator in combination with 840 Touch Control, PC Control or tiamo.
The advantages at a glance:
With instruments of the Robotic Soliprep family, neither deviant results nor time-consuming manual routines are an issue. The solid substance is simply weighed out and placed in the sample rack – all the rest is done fully automatically.
Depending on the model selected, different steps can be combined – including the direct connection to a chromatograph or the titration of the homogenised sample.
Ion chromatography is the method of choice to determine active ingredients, excipients and traces of impurities and metabolites in the form of organic and inorganic ions or polar substances in a number of pharmaceuticals, pharmaceutical solutions or body fluids. In particular, Metrohm ion chromatography systems handle demanding analytical challenges such as the determination of impurities in pharmaceuticals, active pharmaceutical ingredients and pharmaceutical solutions.
Metrohm has taken ion chromatography to an entirely new level. The 850 Professional IC is the first ion chromatography system made up of intelligent components.
Voltammetry also enables organic compounds to be determined with a high degree of sensitivity. This makes it possible to analyse many active pharmaceutical ingredients according to USP<801>.
The 797 VA Computrace is a modern measuring stand that allows voltammetric and polarographic determinations to be performed.
Some application examples:
Metrohm is exclusively represented in more than 80 countries, more than 40 of which have their own subsidiaries. This guarantees a tight network for sales and service.
Neopharma opened a new pharmaceutical plant in Abu Dhabi, United Arab Emirates, in July 2003.
In June 2006, US-based pharmaceutical company Bristol-Myers Squibb pledged to build a large-scale multi-product biopharmaceutical manufacturing plant in Devens, Massachusetts.
In July 2006 Novartis announced that it would build a new vaccine manufacturing facility in Holly Springs, North Carolina, US.
Eli Lilly made a commitment to invest approximately $400m in a biologics manufacturing facility in December 2006.
Merrion's new R&D facility located in Citywest, south Dublin, Ireland is a state-of-the-art facility designed to accommo
Genzyme Corporation is one of most prominent biotechnology companies in the US. Based in Cambridge, Massachusetts, it wa
On 2 November 2009, Novartis officially opened its new global technical centre Suzhou Novartis Pharma Technology Co in R
The Novartis Institute of BioMedical Research (CNBIR) is located in the Zhangjiang High-Tech Park in the Pudong New Area
The University of Maryland in Baltimore has developed a state-of-the-art BioPark on the urban campus of the university.
Cambrex Profarmaco, Cambrex's Milan facility, is a cGMP manufacturing facility located 25km southeast of Milan, Italy. T
Pronova BioPharma is one of the leading companies in the research and development of marine-originated omega-3 fatty aci
A leading provider of contract manufacturing and packaging services, Norwich Pharmaceuticals has served the pharmaceutic
The vaccine manufacturing plant of GlaxoSmithKline (GSK) in Dresden, Germany mainly produces the company's seasonal infl
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its
US formulation development company CoreRx Pharmaceuticals (CoreRx), initiated a major expansion of its manufacturing sit
Canadian contract drug maker Patheon, completed the expansion of its Toronto manufacturing facility in April 2009, two m
Genzyme Corporation is one of the world's leading biotechnology companies, which has been in operation since 1981. G
Amylin Pharmaceuticals is a biopharmaceutical firm located in San Diego, California, with over 1,000 employees in the US
PharmStar Pharmaceuticals Inc is a relatively new drug manufacturer, which is headquartered in Rocky Mount, North Caroli
Sanofi Pasteur, the vaccines division of Sanofi Aventis, is focusing on a continuing technology upgrade and expansion. T
Merck Sharpe and Dohme, the world's seventh largest pharmaceutical company, has a highly successful vaccine division
Cipla Medpro Pharmaceuticals is listed on the Johannesburg Securities Exchange and is one of South Africa's top ten and
Rentschler Biotechnologie GmbH is a full-service contract manufacturer and part of the Rentschler Group based in Lauphei
Accucaps Industries is a contract manufacturer for the soft gelatine encapsulation of pharmaceutical and nutritional compounds based in North America. The company has been in operation since 1989.
Biopolis is a custom-built biomedical research and development (R&D) hub at One-North, Buona Vista, Queenstown, Singapore. Covering 183ha of land, the hub is aimed to benefit a range of disciplines.
Genentech is one of the most successful biotech companies on a world scale with four drugs prominent on the commercial m
Shanghai CP Guojian Pharmaceutical Co Ltd (CPGJ) is a biopharmaceutical company that was formed in January 1998. The com
Bristol-Myers Squibb (BMS) has been undergoing much the same rationalisation process as many large pharmaceutical compan
Boehringer Ingelheim is a Germany-based company with interests in pharmaceuticals, biopharmaceuticals, chemicals and ani
HIV, AIDS and malaria are massive problems throughout Africa. The drugs to treat and prevent these diseases are readily
Novartis is a multinational pharmaceutical company, based in Basel in Switzerland. The company has plants situated acros
In 2006, Bristol-Myers Squibb (BMS) announced a major investment of $220m (€176m) for the expansion of its biol
Puerto Rico has a growing reputation as a biotech and pharmaceutical hub ('Bio Island') and plays host to manufacturing facilities from the world's largest pharmaceutical companies.
GlaxoSmithKline (GSK) has had a presence in Singapore since the 1970s with its investment in an antibiotics plant. Since
Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy.
In September 2006 MedImmune, a Maryland-based biologics company working in the areas of infectious diseases, cancer and
Sanofi Pasteur, the vaccines business of Sanofi-Aventis, is one of the largest seasonal influenza vaccine producers in t
Roche Carolina is the highly successful US subsidiary of pharmaceutical giant Hoffmann La Roche. Roche has operated a pr
In June 2007, Genzyme Corporation announced the construction of a new biomanufacturing plant in Lyon, France. The compan
KBI BioPharma, a division of Atlanta-based Kinetic Biosystems Inc, decided in late 2003 that the home of its new contrac
CORTEX, the Center of Research, Technology & Entrepreneurial Exchange, has constructed a new biotech complex to encourag
In early 2007 Technip was awarded a contract by the Chengdu Institute of Biological Products (CDIBP) for the design, con
Berlex Laboratories LLC based in Bothell, Washington was the US subsidiary of the German pharmaceutical company Schering
Roche operates in China as Shanghai Roche Pharmaceutical Co Limited, which is a highly successful joint venture operated
Vetter is a leading contract development manufacturing organisation that specialises in the aseptic filling of liquid and lyophilised drugs for international biotechnology and pharmaceutical companies.
Roche's biotechnology plant in Basel opened in May 2007. The plant was developed on the existing Roche production site,
Genzyme Corporation is one of the world's leading biotech manufacturers and announced the establishment of a manufacturi
The Biosite headquarters and manufacturing unit in Mera Misa, San diego, California was completed in August 2006. Biosi
Novo Nordisk has had research and production facilities in China since 1994 when the company set up Novo Nordisk (Tianji
The NovoSeven pharmaceutical facility in Hillerød, Denmark was constructed by NNE (Novo Nordisk Engineering), the e
In October 2006 Eli Lilly completed the first phase of its biotech facility expansion in Indianapolis, which was made re
Biolex Therapeutics is a biotech company involved in the development and commercialisation of complex proteins and monoc
Genzyme Flanders is a European subsidiary of the US biotech giant Genzyme Corporation. The 70,000ft² facility in Ge
The production plant at Loughbeg in County Cork, Ireland, is currently owned by Hovione.
Cook Pharmica LLC, the newest Cook Group company, completed the construction of a $70m biotechnology facility in Blo
Merck's 272,000ft² vaccine production plant is located on a 262-acre site in Treyburn Corporate Park on the north s
Stirling Pharma's pharmaceutical plant in North Sydney, Nova Scotia, Canada, on a 300-acre business park was commissione
Elan Pharma is a biopharmaceutical company working in the development of drugs for the treatment of a wide range of ther
Roche Diagnostics completed the construction and commissioning of a new manufacturing facility in Branchburg, New Jersey
Centocor, a subsidiary of Johnson & Johnson, announced in July 2004 the investment of €500m in the constructio
AstraZeneca France's Dunkirk plant has been sold to Minafin, a subsidiary of the Minakem Group. The acquisition was comp
The NIMO (New Idec Manufacturing Operation) in Oceanside, San Diego, was originally built by Idec as the company wanted
The Danish biotech company Bavarian Nordic has set up a new smallpox vaccine production facility in Kvistgård, Nort
Serologicals Corporation finished the construction of a new biotechnology production facility in Lawrence, Kansas, US, i
In April 2001 Eli Lilly announced it was constructing a new biotech bulk manufacturing facility in Carolina, Puerto Rico
Novo Nordisk decided in the spring of 2003 to market the long-acting insulin analogue Levemir (Insulin Detemir) first in
Merck Sharpe & Dohme, known as MSD Technology Singapore Pte Ltd in Singapore, opened their newest manufacturing facility
Ferring Pharmaceuticals announced its intention in 2003 to build a new production site at Saint-Prex, Canton of Vaud in
Lonza Biotec completed the construction of new manufacturing capacity with a multi-product design at Visp in Switzerland
Early in 2003, Aventis Pharma Germany completed their third insulin plant in Frankfurt, Germany. The new plant produces
Schering-Plough has continued to capitalise on its investment program into facilities based in Singapore. The company cu
In March 2002 Boehringer Ingelheim opened their new manufacturing facility in Pudong, Zhangjiang High Tech Park in Shang
Avecia Biotechnology announced a $100m investment in a new advanced centre for biologics manufacture in Billingham,
VaxGen opened a new biopharmaceutical manufacturing facility in South San Francisco, California, US in June 2003. The fa
Baxter BioPharma Solutions is a contract manufacturer of pre-filled syringes, vials and cartridges for the packaging of vaccines and drugs to treat chronic conditions such as rheumatoid arthritis and multiple sclerosis.
DSM Biologics completed the construction of the first phase of a substantial expansion to its large-scale biopharmaceuti
Lonza Biologics completed the large-scale expansion of their facility in Portsmouth, New Hampshire, Pease International
In March 2003 Biogen Idec began construction of its first production facility to be located outside of the USA. The plan
Boehringer Ingelheim officially opened the new active ingredients plant in Ingelheim in early 2003. The plant will be ab
In September 1999 Novartis opened a new pharmaceutical production facility at the Schweizerhalle site near Basel, Switzerland.
In March 1999 Rohner AG began the construction of a new state-of-the-art pharmaceutical facility at its existing site at
Bothell is the site of a process development facility owned by the pharmaceuticals firm Immunex (now owned by Amgen).
Achillion Pharmaceuticals was founded in February 2000 as one of the largest biotech start-ups in the USA.
West Greenwich, Rhode Island, US, is the site of a new pharmaceutical manufacturing facility dedicated to the production
ChemSyn Laboratories (now Aptuit), a leading producer of anti-cancer bulk pharmaceuticals and other high potency chemica
Novartis Pharmaceuticals' active pharmaceutical ingredients (API) plant complex in Grimsby, West Yorkshire, was first established in 1951.
Johnson & Johnson (J&J) subsidiary Janssen Pharmaceutica decided to build a new pharmaceutical plant in Geel in Belgium in 1998.
Between 1997 and 1999, Merck Sharp and Dohme (MSD) undertook a two-year expansion of its manufacturing facility in Ballydine Co Tipperary, Ireland.
In August 2000, the Bayer Corporation was granted permission by the city of Berkeley to develop an additional 14 acres s
In July 1997, AstraZeneca announced plans to invest £15m in its Guayama facility in Puerto Rico.
In 2000, Nycomed Amersham announced it would open a new pharmaceutical plant in Shanghai on 27 October.
In January 2000, ImClone Systems began construction of a new 100,000ft² biopharmaceutical manufacturing facility in Branchburg, New Jersey.
In early 2001, AstraZeneca inaugurated a pharmaceutical plant in the Wuxi region of northeastern China.
In June 2000, Daiichi Sankyo Company opened a new pharmaceutical plant in Beijing.
The large-scale pharmaceutical facility in Tuas, Singapore, is Pfizer's first manufacturing facility in the country.
In 1998, Glaxo Wellcome made an investment in a production facility in Suzhou in the eastern Chinese province of Jiangsu.
In April 2000, Lundbeck Pharmaceuticals was awarded contracts for the construction of a bulk pharmaceutical facility in Seal Sands, Teesside, UK.
Hoffman La Roche completed the first phase of construction for a vitamins and minerals premix plant at Isando, Republic of South Africa, in June 2002.
In 1999, construction began on a derivatives plant for Protchem Industries.
The CSL Parkville facility has undergone several phases of expansion since 1997 when it was first opened. The production facilities have been expanded three times.
Novo Nordisk is upgrading the insulin production plant at its facility in Chartres, Eure-et-Loir region, France. The Dan
Roche's latest vitamin plant is located in Taishan, Shanghai, which is in the northeastern part of the Peoples' Republic of China.
Lonza Fine Chemicals and Specialties put a production facility for niacinamide into operation in 1997 following a joint venture (JV) agreement with the Guangzhou Pesticide Factory.
Hoffman La Roche built a vitamin premix plant in 2000 at El Salto in Jalisco, Mexico, to expand its operations in the premix vitamin market.
In 1999, UK-based pharmaceuticals company Glaxo Wellcome instigated a project to expand its 652,000ft² manufacturing and packaging plant in Zebulon, NC.
Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology